Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 1

Status

Not yet recruiting 3Terminated 2Recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 6Carcinoma, Hepatocellular 6Sarcoma 2Rectal Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Gastrointestinal Stromal Tumors 2Solid Malignant Tumors 1Sarcoma, Ewing 1Recurrence 1Piebaldism 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Osteosarcoma 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Metastasis Colon Cancer 1HER2 IHC3+ Advanced Colorectal Cancer 1Glioblastoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease Progression 1Bone Neoplasms 1

Interventions

Bevacizumab 36atezolizumab 25durvalumab 22Nivolumab 21lenvatinib 20tremelimumab 15Specimen Handling 15Magnetic Resonance Spectroscopy 12sintilimab 11pembrolizumab 11Ipilimumab 10tislelizumab 7X-Rays 7Radiosurgery 7Immunoglobulin G 7regorafenib 6Sorafenib 6Disulfides 6Cyclophosphamide 6Radiotherapy 5cabozantinib 4Radiation 4Oxaliplatin 4Immunotherapy 4Fluorouracil 4Ethiodized Oil 4Blood Specimen Collection 4Biopsy 4fludarabine 3Photons 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × regorafenib × 90 days × Clear all
NCT07495579 2026-05-27

REVIVE

Asan Medical Center

Phase 2 Not yet recruiting
146 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06902246 2026-05-01

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

University of Miami

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07514429 2026-04-07

RELEVANT-HCC

Asan Medical Center

Phase 2 Not yet recruiting
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT07514455 2026-04-07

RECOMEND

Asan Medical Center

Phase 2 Not yet recruiting
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Disease Progression

NCT04777851 2026-03-09

REPLACE

Translational Research in Oncology

Phase 3 Terminated
45 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT04327700 2026-03-05

Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib

Wake Forest University Health Sciences

Phase 2 Terminated
2 enrolled 10 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡